查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲下一代 IVD 市場：分析與預測（2023-2033）
市場調查報告書
商品編碼
1421496

歐洲下一代 IVD 市場：分析與預測（2023-2033）

Europe Next Generation IVD Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 117 Pages | 商品交期: 1-5個工作天內

價格

2023年歐洲下一代IVD市場規模將達242億美元。

預計2023年至2033年該市場將以5.26%的複合年成長率成長，2033年達到404.1億美元。利用診斷領域的新技術和創新有能力刺激下一代 IVD（體外診斷）市場的擴張。分子診斷、基因組學和次世代定序(NGS) 預計將成為這一成長的關鍵驅動力，為增強疾病診斷提供新的機會，進而重塑患者的治療結果。

主要市場統計數據
預測期 2023-2033
2023年評估價值 242億美元
2033年預測 404.1億美元
複合年成長率 5.26%

歐洲的下一代 IVD（體外診斷）市場正在經歷顯著的成長和轉型。該市場包括各種先進的診斷技術和工具，正在徹底改變該地區的醫療保健。推動這一市場的關鍵因素包括慢性病的流行、個人化醫療需求的增加以及對疾病早期檢測和管理的日益重視。分子診斷、基因組學和次世代定序(NGS) 處於技術創新的前沿，使醫療保健專業人員能夠準確地了解患者的病情。這些技術提高了診斷各種疾病的準確性、速度和效率，包括癌症、感染疾病和遺傳性疾病。

此外，歐洲市場的特點是研發活動活躍，促進了 IVD 解決方案的不斷進步。監管支持和嚴格的品質標準確保這些診斷的安全性和有效性。歐洲下一代 IVD 市場專注於改善患者治療效果和最佳化醫療資源，有望持續成長和創新，為改善該地區的整體醫療保健做出貢獻。Masu。

該報告考察了歐洲下一代 IVD 市場，並提供了市場概述，包括按類型、最終用戶、國家/地區分類的趨勢以及進入市場的公司概況。

目錄

執行摘要

第1章 市場

  • 市場範圍
  • 調查方法

第2章 市場概況

  • 介紹
    • 下一代IVD市場前景
    • 市場規模和成長潛力
    • 下一代體外診斷市場的產品基準（按類型）
  • COVID-19 對下一代 IVD 市場的影響

第3章行業分析

  • 法律要求
    • 歐洲法律要求和框架

第4章市場動態

  • 概述
  • 影響分析
  • 市場驅動力
  • 市場挑戰
  • 市場機會

第 5 章 下一代 IVD 市場，按地區，百萬美元，2022-2033

  • 概述
  • 歐洲
    • 市場動態
    • 市場規模及預測

第6章 公司簡介

  • bioMerieux SA（BioFire Diagnostics）
  • F. Hoffmann-La Roche Ltd.（Roche Molecular Systems, Inc.）
  • QIAGEN NV
  • Siemens Healthineers AG
Product Code: BHP1842S

“The Europe Next-Generation IVD Market Expected to Reach $40.41 Billion by 2033.”

Introduction to Europe Next-Generation IVD (In vitro diagnostics) Market

The Europe next-generation IVD market was valued at $24.20 billion in 2023 and is expected to reach $40.41 billion by 2033, growing at a CAGR of 5.26% between 2023 and 2033. The utilization of emerging technologies and innovations in diagnostics has the capacity to stimulate the expansion of the next-generation IVD (In Vitro Diagnostic) market. Molecular diagnostics, genomics, and Next-Generation Sequencing (NGS) are anticipated to be key drivers of this growth, offering fresh opportunities for enhanced disease diagnosis and, consequently, reshaping patient outcomes.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$24.20 Billion
2033 Forecast$40.41 Billion
CAGR5.26%

Market Introduction

The Europe Next-Generation IVD (In Vitro Diagnostics) Market is witnessing significant growth and transformation. It encompasses a diverse range of advanced diagnostic technologies and tools that are revolutionizing healthcare practices in the region. Key factors driving this market include the increasing prevalence of chronic diseases, rising demand for personalized medicine, and a growing emphasis on early disease detection and management. Molecular diagnostics, genomics, and Next-Generation Sequencing (NGS) are at the forefront of innovation, enabling healthcare professionals to obtain precise insights into patients' conditions. These technologies offer enhanced accuracy, speed, and efficiency in diagnosing various diseases, including cancer, infectious diseases, and genetic disorders.

Moreover, the Europe market is characterized by robust research and development activities, fostering continuous advancements in IVD solutions. Regulatory support and stringent quality standards ensure the safety and efficacy of these diagnostics. With a focus on improving patient outcomes and optimizing healthcare resources, the Europe Next-Generation IVD Market is poised for continued growth and innovation, contributing to the region's overall healthcare excellence.

Market Segmentation:

Segmentation 1: by Type

  • Core Laboratory Diagnostics
  • POC Testing
  • Molecular Diagnostics

Segmentation 2: by End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Academic and Research Institutions
  • Other End Users

Segmentation 3: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The Europe next-generation IVD market has been extensively segmented on the basis of various categories, such as type and end user. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe next-generation IVD market has numerous startups paving their way into manufacturing kits, panels, assays, and instruments and entering the market. Key players in the Europe next-generation IVD market analyzed and profiled in the study involve established players that offer various kinds of disease-specific panels and multiplex instruments.

Table of Contents

Executive Summary

1. Markets

  • 1.1. Market Scope
    • 1.1.1. Key Questions Answered in the Report
  • 1.2. Research Methodology
    • 1.2.1. Next-Generation IVD Market: Research Methodology
    • 1.2.2. Data Sources
      • 1.2.2.1. Primary Data Sources
      • 1.2.2.2. Secondary Data Sources
    • 1.2.3. Market Estimation Model
    • 1.2.4. Criteria for Company Profiling

2. Market Overview

  • 2.1. Introduction
    • 2.1.1. Next-Generation IVD Market Outlook
      • 2.1.1.1. POC-IVD
      • 2.1.1.2. Diagnostic Expenditures
      • 2.1.1.3. Pricing Patterns of Next-Generation IVD
    • 2.1.2. Market Size and Growth Potential
      • 2.1.2.1. Short-Term Impact (2020-2025)
      • 2.1.2.2. Long-Term Impact (2026-2033)
    • 2.1.3. Product Benchmarking by Next- Generation In-vitro Diagnostics Market, (by Type)
  • 2.2. COVID-19 Impact on the Next-Generation IVD Market
    • 2.2.1. Impact on Operations
    • 2.2.2. COVID-19 Impact: Current Scenario of the Market
    • 2.2.3. Pre-COVID Assessment
    • 2.2.4. Post-COVID-19 Market Assessment

3. Industry Analysis

  • 3.1. Legal Requirements
    • 3.1.1. Legal Requirements and Framework in Europe

4. Market Dynamics

  • 4.1. Overview
  • 4.2. Impact Analysis
  • 4.3. Market Drivers
    • 4.3.1. Technological Advancements in Next-Generation In-Vitro Diagnostics Transforming Healthcare System
    • 4.3.2. Rising Demand of POC Testing Boosting Next-Generation IVD Market
    • 4.3.3. Growing Incidence of Chronic and Acute Diseases Demanding for Early Treatment
    • 4.3.4. Boost in the Next-Generation IVD Market during COVID-19 Pandemic
  • 4.4. Market Challenges
    • 4.4.1. Regulatory Hurdles Related to Next-Generation IVD Technologies
    • 4.4.2. Poor Reimbursement Scenario
  • 4.5. Market Opportunities
    • 4.5.1. Rising Number of Next-Generation IVD Companies Involved in Business Expansion
    • 4.5.2. Inclination of Emerging Companies toward Next-Generation IVD

5. Next-Generation IVD Market, by Region, $Million, 2022-2033

  • 5.1. Overview
  • 5.2. Europe
    • 5.2.1. Market Dynamics
    • 5.2.2. Market Size and Forecast
      • 5.2.2.1. Europe Next-Generation IVD Market (by End User)
      • 5.2.2.2. Europe Next-Generation IVD Market (by Type)
        • 5.2.2.2.1. Europe Next-Generation Core Laboratory IVD Market, (by Type)
      • 5.2.2.3. Europe Next-Generation IVD Market (by Country)
        • 5.2.2.3.1. Germany
          • 5.2.2.3.1.1. Market Size and Forecast
          • 5.2.2.3.1.1.1. Germany Next-Generation IVD Market (by End User)
          • 5.2.2.3.1.1.2. Germany Next-Generation IVD Market (by Type)
        • 5.2.2.3.2. France
          • 5.2.2.3.2.1. Market Size and Forecast
          • 5.2.2.3.2.1.1. France Next-Generation IVD Market (by End User)
          • 5.2.2.3.2.1.2. France Next-Generation IVD Market (by Type)
        • 5.2.2.3.3. U.K.
          • 5.2.2.3.3.1. Market Size and Forecast
          • 5.2.2.3.3.1.1. U.K. Next-Generation IVD Market (by End User)
          • 5.2.2.3.3.1.2. U.K. Next-Generation IVD Market (by Type)
        • 5.2.2.3.4. Italy
          • 5.2.2.3.4.1. Market Size and Forecast
          • 5.2.2.3.4.1.1. Italy Next-Generation IVD Market (by End User)
          • 5.2.2.3.4.1.2. Italy Next-Generation IVD Market (by Type)
        • 5.2.2.3.5. Spain
          • 5.2.2.3.5.1. Market Size and Forecast
          • 5.2.2.3.5.1.1. Spain Next-Generation IVD Market (by End User)
          • 5.2.2.3.5.1.2. Spain Next-Generation IVD Market (by Type)
        • 5.2.2.3.6. Rest-of-Europe
          • 5.2.2.3.6.1. Market Size and Forecast
          • 5.2.2.3.6.1.1. Rest-of-Europe Next-Generation IVD Market (by End User)
          • 5.2.2.3.6.1.2. Rest-of-Europe Next-Generation IVD Market (by Type)

6. Company Profiles

  • 6.1. Overview
  • 6.2. bioMerieux SA (BioFire Diagnostics)
    • 6.2.1. Company Overview
    • 6.2.2. Role of bioMerieux SA (BioFire Diagnostics) in the Next-Generation IVD Market
    • 6.2.3. Financials
    • 6.2.4. Recent Developments
      • 6.2.4.1. Corporate Strategies
      • 6.2.4.2. Business Strategies
    • 6.2.5. Analyst Perspective
  • 6.3. F. Hoffmann-La Roche Ltd. (Roche Molecular Systems, Inc.)
    • 6.3.1. Company Overview
    • 6.3.2. Role of F. Hoffmann-La Roche Ltd. in the Next-Generation IVD Market
    • 6.3.3. Financials
    • 6.3.4. Recent Developments
      • 6.3.4.1. Business Strategies
    • 6.3.5. Analyst Perspective
  • 6.4. QIAGEN N.V.
    • 6.4.1. Company Overview
    • 6.4.2. Role of QIAGEN N.V. in the Next-Generation IVD Market
    • 6.4.3. Financials
    • 6.4.4. Recent Developments
      • 6.4.4.1. Corporate Strategies
      • 6.4.4.2. Business Strategies
    • 6.4.5. Analyst Perspective
  • 6.5. Siemens Healthineers AG
    • 6.5.1. Company Overview
    • 6.5.2. Role of Siemens Healthineers AG in the Next-Generation IVD Market
    • 6.5.3. Financials
    • 6.5.4. Recent Developments
      • 6.5.4.1. Corporate Strategies
      • 6.5.4.2. Business Strategies
    • 6.5.5. Analyst Perspective

List of Figures

  • Figure 1: Facts about Europe Next-Generation IVD Market
  • Figure 2: Equipment's used for Next-Generation In-Vitro Diagnostics
  • Figure 3: Europe Next-Generation IVD Market, $Billion, 2022 and 2033
  • Figure 4: Trend Analysis of Next-Generation In-vitro Diagnostics Ecosystem
  • Figure 5: Common Chronic Conditions for Population Above 65 years
  • Figure 6: Key Challenges in the Europe Next-Generation IVD Market based on Primary Respondents
  • Figure 7: New In-Vitro Diagnostics Regulations (IVDR) and Medical Device Regulation (MDR)
  • Figure 8: Major Highlights Witnessed in the Next-Generation IVD Market During COVID-19 Impact
  • Figure 9: Role of POC Diagnostics in Next-Generation IVD Market During Pandemic
  • Figure 10: Leading and Emerging Companies in the Next-Generation IVD Ecosystem
  • Figure 11: Leading Companies in the Next-Generation IVD Ecosystem and Their Market Share (%)
  • Figure 12: Key Developments Undertaken by Companies in the Next-Generation IVD Market, July 2019-June 2023
  • Figure 13: Product Benchmarking of Next-Generation In-Vitro Diagnostics Ecosystem (by Test)
  • Figure 14: Europe Next-Generation IVD Market (by Type), Share (%), 2022 and 2033
  • Figure 15: Europe Next-Generation IVD Market (by End User), Share (%), 2022 and 2033
  • Figure 16: Europe Next-Generation IVD Market, Market Snapshot
  • Figure 17: Next-Generation IVD Market: Research Methodology
  • Figure 18: Primary Research Methodology
  • Figure 19: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 20: Top-Down Approach (Segment-Wise Analysis)
  • Figure 21: Europe Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 22: Product Benchmarking of Next-Generation In-vitro Diagnostics Market (by Type)
  • Figure 23: In-Vitro Diagnostic Trends during the COVID-19 Pandemic
  • Figure 24: Timeline of IVDR 2017/746
  • Figure 25: Next-Generation IVD Market Dynamics
  • Figure 26: Factors Contributing to Growing Demand of POC Testing
  • Figure 27: Current Trend in In-Vitro Diagnostics: From Centralized Laboratory to Point-of-Care Testing
  • Figure 28: Annual Mortality by Chronic Illness in 1990, 2002, and 2020
  • Figure 29: Trend in COVID-19 Diagnostic Test Development and the Used Technology
  • Figure 30: Top Challenges in the IVDR Compliance
  • Figure 31: Key Area of Focus by Next-Generation IVD Companies
  • Figure 32: Next-Generation IVD Market (by Region), Share (%), 2022
  • Figure 33: Next-Generation IVD Market (by Region), $Billion, 2022-2033
  • Figure 34: Europe Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 35: Europe Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 36: Europe Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 37: Europe Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 38: Europe Next-Generation IVD Market (by Country), $Billion, 2022-2033
  • Figure 39: Germany Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 40: Germany Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 41: Germany Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 42: Germany Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 43: France Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 44: France Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 45: France Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 46: France Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 47: U.K. Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 48: U.K. Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 49: U.K. Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 50: U.K. Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 51: Italy Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 52: Italy Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 53: Italy Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 54: Italy Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 55: Spain Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 56: Spain Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 57: Spain Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 58: Spain Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 59: Rest-of-Europe Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 60: Rest-of-Europe Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 61: Rest-of-Europe Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 62: Rest-of-Europe Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 63: Total Number of Companies Profiled
  • Figure 64: bioMerieux SA (BioFire Diagnostics): Product Portfolio
  • Figure 65: bioMerieux SA (BioFire Diagnostics): Overall Financials, $Million, 2020-2022
  • Figure 66: bioMerieux SA (BioFire Diagnostics): Revenue (by Segment), $Million, 2020-2022
  • Figure 67: bioMerieux SA (BioFire Diagnostics): Revenue (by Region), $Million, 2020-2022
  • Figure 68: bioMerieux SA (BioFire Diagnostics): R&D Expenditure, $Million, 2020-2022
  • Figure 69: F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Figure 70: F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2020-2022
  • Figure 71: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2020-2022
  • Figure 72: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2020-2022
  • Figure 73: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2020-2022
  • Figure 74: QIAGEN N.V.: Product Portfolio
  • Figure 75: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
  • Figure 76: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
  • Figure 77: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
  • Figure 78: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
  • Figure 79: Siemens Healthineers AG: Product Portfolio
  • Figure 80: Siemens Healthineers AG: Overall Financials, $Million, 2020-2022
  • Figure 81: Siemens Healthineers AG: Revenue (by Segment), $Million, 2020-2022
  • Figure 82: Siemens Healthineers AG: Revenue (by Region), $Million, 2020-2022
  • Figure 83: Siemens Healthineers AG: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Impact Analysis of Market Drivers, and Restraints on the Europe Next-Generation IVD Market
  • Table 2: Impact of COVID-19 on Different Countries
  • Table 3: Likert Scale
  • Table 4: Impact Analysis of Market Drivers
  • Table 5: Impact Analysis of Market Restraints
  • Table 6: Impact Analysis of Market Opportunities
  • Table 7: Technology Offered by Next-Generation IVD Ecosystem
  • Table 8: Examples of Expansion Strategy by Next-Generation IVD Market Players
  • Table 9: Europe: Market Dynamics